Emerging mechanisms and therapeutics in inflammatory muscle diseases
Idiopathic inflammatory myopathies (IIMs), or myositis, are rare diseases marked by immune-driven muscle damage and complications like skin lesions and interstitial lung disease (ILD). Despite advances, challenges in diagnosis and treatment persist, particularly in inclusion body myositis (IBM), whe...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
March 2025
|
| In: |
Trends in pharmacological sciences
Year: 2025, Volume: 46, Issue: 3, Pages: 249-263 |
| ISSN: | 1873-3735 |
| DOI: | 10.1016/j.tips.2025.01.005 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.tips.2025.01.005 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0165614725000057 
|
| Author Notes: | Sven Wischnewski, Hans-Werner Rausch, Chiseko Ikenaga, Jan Leipe, Thomas E. Lloyd, and Lucas Schirmer |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1928250874 | ||
| 003 | DE-627 | ||
| 005 | 20250616095010.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250616s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.tips.2025.01.005 |2 doi | |
| 035 | |a (DE-627)1928250874 | ||
| 035 | |a (DE-599)KXP1928250874 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Wischnewski, Sven |e VerfasserIn |0 (DE-588)1239209053 |0 (DE-627)1767282788 |4 aut | |
| 245 | 1 | 0 | |a Emerging mechanisms and therapeutics in inflammatory muscle diseases |c Sven Wischnewski, Hans-Werner Rausch, Chiseko Ikenaga, Jan Leipe, Thomas E. Lloyd, and Lucas Schirmer |
| 264 | 1 | |c March 2025 | |
| 300 | |b Illustrationen | ||
| 300 | |a 15 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffetlicht: 11. Februar 2025, Artikelversion: 6. März 2025 | ||
| 500 | |a Gesehen am 16.06.2025 | ||
| 520 | |a Idiopathic inflammatory myopathies (IIMs), or myositis, are rare diseases marked by immune-driven muscle damage and complications like skin lesions and interstitial lung disease (ILD). Despite advances, challenges in diagnosis and treatment persist, particularly in inclusion body myositis (IBM), where no effective therapy exists. Recent breakthroughs, including transcriptomics and insights into antibody-mediated immunity and interferon (IFN) signaling, have clarified IIM pathophysiology and spurred the development of new therapies, such as chimeric antigen receptor (CAR) T cells and Janus kinase (JAK) inhibitors. We explore the latest findings on the mechanisms underlying adult-onset IIMs, emphasizing IBM pathobiology and its unique immune and degenerative pathways, such as a selective type 2 myofiber damage and severe cell stress. Finally, we highlight the recent advances in transcriptomics, single-cell analysis, and machine learning in transforming IIM research by improving diagnostic accuracy, uncovering therapeutic targets, and supporting the development of personalized treatment strategies. | ||
| 650 | 4 | |a antisynthetase syndrome | |
| 650 | 4 | |a dermatomyositis | |
| 650 | 4 | |a idiopathic inflammatory myopathy | |
| 650 | 4 | |a immune-mediated necrotizing myopathy | |
| 650 | 4 | |a inclusion body myositis | |
| 650 | 4 | |a muscle inflammation | |
| 700 | 1 | |a Rausch, Hans-Werner |e VerfasserIn |0 (DE-588)1178612511 |0 (DE-627)1049483154 |0 (DE-576)517822148 |4 aut | |
| 700 | 1 | |a Ikenaga, Chiseko |e VerfasserIn |4 aut | |
| 700 | 1 | |a Leipe, Jan |d 1976- |e VerfasserIn |0 (DE-588)131797824 |0 (DE-627)51426280X |0 (DE-576)298758563 |4 aut | |
| 700 | 1 | |a Lloyd, Thomas E. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schirmer, Lucas |d 1981- |e VerfasserIn |0 (DE-588)140880631 |0 (DE-627)70381737X |0 (DE-576)321212088 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Trends in pharmacological sciences |d Amsterdam [u.a.] : Elsevier Science, 1979 |g 46(2025), 3, Seite 249-263 |h Online-Ressource |w (DE-627)320490912 |w (DE-600)2011007-8 |w (DE-576)116726067 |x 1873-3735 |7 nnas |a Emerging mechanisms and therapeutics in inflammatory muscle diseases |
| 773 | 1 | 8 | |g volume:46 |g year:2025 |g number:3 |g pages:249-263 |g extent:15 |a Emerging mechanisms and therapeutics in inflammatory muscle diseases |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.tips.2025.01.005 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0165614725000057 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250616 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 140880631 |a Schirmer, Lucas |m 140880631:Schirmer, Lucas |d 60000 |d 62700 |e 60000PS140880631 |e 62700PS140880631 |k 0/60000/ |k 1/60000/62700/ |p 6 |y j | ||
| 998 | |g 131797824 |a Leipe, Jan |m 131797824:Leipe, Jan |d 60000 |d 61400 |e 60000PL131797824 |e 61400PL131797824 |k 0/60000/ |k 1/60000/61400/ |p 4 | ||
| 998 | |g 1178612511 |a Rausch, Hans-Werner |m 1178612511:Rausch, Hans-Werner |d 60000 |d 62700 |e 60000PR1178612511 |e 62700PR1178612511 |k 0/60000/ |k 1/60000/62700/ |p 2 | ||
| 998 | |g 1239209053 |a Wischnewski, Sven |m 1239209053:Wischnewski, Sven |d 60000 |d 62700 |e 60000PW1239209053 |e 62700PW1239209053 |k 0/60000/ |k 1/60000/62700/ |p 1 |x j | ||
| 999 | |a KXP-PPN1928250874 |e 4734532826 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1928250874","physDesc":[{"noteIll":"Illustrationen","extent":"15 S."}],"origin":[{"dateIssuedDisp":"March 2025","dateIssuedKey":"2025"}],"relHost":[{"note":["Gesehen am 28.05.20","Ungezählte Beil.: Supplement"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"title":[{"title":"Trends in pharmacological sciences","title_sort":"Trends in pharmacological sciences"}],"part":{"pages":"249-263","extent":"15","text":"46(2025), 3, Seite 249-263","issue":"3","year":"2025","volume":"46"},"id":{"eki":["320490912"],"issn":["1873-3735"],"zdb":["2011007-8"]},"pubHistory":["1.1979/80 -"],"origin":[{"publisher":"Elsevier Science","publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1979","dateIssuedDisp":"1979-"}],"disp":"Emerging mechanisms and therapeutics in inflammatory muscle diseasesTrends in pharmacological sciences","physDesc":[{"extent":"Online-Ressource"}],"recId":"320490912"}],"person":[{"given":"Sven","role":"aut","family":"Wischnewski","display":"Wischnewski, Sven"},{"role":"aut","given":"Hans-Werner","family":"Rausch","display":"Rausch, Hans-Werner"},{"display":"Ikenaga, Chiseko","role":"aut","given":"Chiseko","family":"Ikenaga"},{"family":"Leipe","given":"Jan","role":"aut","display":"Leipe, Jan"},{"display":"Lloyd, Thomas E.","family":"Lloyd","given":"Thomas E.","role":"aut"},{"display":"Schirmer, Lucas","family":"Schirmer","given":"Lucas","role":"aut"}],"title":[{"title":"Emerging mechanisms and therapeutics in inflammatory muscle diseases","title_sort":"Emerging mechanisms and therapeutics in inflammatory muscle diseases"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Online veröffetlicht: 11. Februar 2025, Artikelversion: 6. März 2025","Gesehen am 16.06.2025"],"name":{"displayForm":["Sven Wischnewski, Hans-Werner Rausch, Chiseko Ikenaga, Jan Leipe, Thomas E. Lloyd, and Lucas Schirmer"]},"id":{"eki":["1928250874"],"doi":["10.1016/j.tips.2025.01.005"]}} | ||
| SRT | |a WISCHNEWSKEMERGINGME2025 | ||